1. Executive Summary
1.1.Regional Market Share
1.2. Business Trends
1.3. Virtual Clinical Trials Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1. Research Objective
2.2. Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6.Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1. Market Definition
3.2.Virtual Clinical Trials Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. Virtual Clinical Trials Market – Industry Insights
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7. Market Dynamics
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restrictions
7.5. Market Trends
8. Market Analysis
8.1. Porters Five Forces
8.2. PEST Analysis
8.2.1. Political
8.2.2. Economic
8.2.3. Social
8.2.4. Technological
9. Virtual Clinical Trials Market
9.1. Overview
9.2.Historical Analysis (2016-2021)
9.2.1. Market Size, YoY Growth (%) and Market Forecast
10. Virtual Clinical Trials Market Size & Forecast 2022A-2032F
10.1. Overview
10.2. Key Findings
10.3. Market Segmentation
10.3.1. By Study Type
10.3.1.1. Interventional
10.3.1.1.1. By Value (USD Million) 2022-2032F
10.3.1.1.2. Market Share (%) 2022-2032F
10.3.1.1.3. YoY Growth (%) 2022-2032F
10.3.1.2. Observational
10.3.1.2.1. By Value (USD Million) 2022-2032F
10.3.1.2.2.Market Share (%) 2022-2032F
10.3.1.2.3.Y-o-Y Growth (%) 2022-2032F
10.3.1.3. Expanded Access
10.3.1.3.1. By Value (USD Million) 2022-2032F
10.3.1.3.2.Market Share (%) 2022-2032F
10.3.1.3.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.By Application
10.3.2.1. Phase I
10.3.2.1.1. By Value (USD Million) 2022-2032F
10.3.2.1.2.Market Share (%) 2022-2032F
10.3.2.1.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.2.Phase II
10.3.2.2.1.By Value (USD Million) 2022-2032F
10.3.2.2.2. Market Share (%) 2022-2032F
10.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.3.Phase III
10.3.2.3.1.By Value (USD Million) 2022-2032F
10.3.2.3.2. Market Share (%) 2022-2032F
10.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.4.Phase IV
10.3.2.4.1. By Value (USD Million) 2022-2032F
10.3.2.4.2.Market Share (%) 2022-2032F
10.3.2.4.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.By Indication
10.3.3.1. CNS
10.3.3.1.1. By Value (USD Million) 2022-2032F
10.3.3.1.2.Market Share (%) 2022-2032F
10.3.3.1.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.2.Autoimmune/Inflammation
10.3.3.2.1.By Value (USD Million) 2022-2032F
10.3.3.2.2. Market Share (%) 2022-2032F
10.3.3.2.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.3.Cardiovascular Disease
10.3.3.3.1.By Value (USD Million) 2022-2032F
10.3.3.3.2.Market Share (%) 2022-2032F
10.3.3.3.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.4.Metabolic/Endocrinology
10.3.3.4.1. By Value (USD Million) 2022-2032F
10.3.3.4.2.Market Share (%) 2022-2032F
10.3.3.4.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.5.Infectious Disease
10.3.3.5.1. By Value (USD Million) 2022-2032F
10.3.3.5.2.Market Share (%) 2022-2032F
10.3.3.5.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.6.Oncology
10.3.3.6.1.By Value (USD Million) 2022-2032F
10.3.3.6.2. Market Share (%) 2022-2032F
10.3.3.6.3. Y-o-Y Growth (%) 2022-2032F
10.3.3.7.Genitourinary
10.3.3.7.1.By Value (USD Million) 2022-2032F
10.3.3.7.2. Market Share (%) 2022-2032F
10.3.3.7.3. Y-o-Y Growth (%) 2022-2032F
10.3.3.8.Ophthalmology
10.3.3.8.1. By Value (USD Million) 2022-2032F
10.3.3.8.2.Market Share (%) 2022-2032F
10.3.3.8.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.9.Others
10.3.3.9.1.By Value (USD Million) 2022-2032F
10.3.3.9.2. Market Share (%) 2022-2032F
10.3.3.9.3. Y-o-Y Growth (%) 2022-2032F
11.North America Virtual Clinical Trials Market Size & Forecast 2022A-2032F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Study Type
11.3.2. By Phase
11.3.3. By Indication
11.4.Country
11.4.1. United States
11.4.2.Canada
12. Europe Virtual Clinical Trials Market Size & Forecast 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Study Type
12.3.2.By Phase
12.3.3.By Indication
12.4. Country
12.4.1.Germany
12.4.2. United Kingdom
12.4.3. France
12.4.4. Italy
12.4.5. Spain
12.4.6. Russia
12.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
13. Asia Virtual Clinical Trials Market Size & Forecast 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Study Type
13.3.2.By Phase
13.3.3.By Indication
13.4. Country
13.4.1.India
13.4.2. China
13.4.3. South Korea
13.4.4. Japan
13.4.5. Rest of APAC
14. Middle East and Africa Virtual Clinical Trials Market Size & Forecast 2022A-2032F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Study Type
14.3.2.By Phase
14.3.3.By Indication
14.4. Country
14.4.1.Israel
14.4.2. GCC
14.4.3. North Africa
14.4.4. South Africa
14.4.5. Rest of Middle East and Africa
15. Latin America Virtual Clinical Trials Market Size & Forecast 2022A-2032F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Study Type
15.3.2. By Phase
15.3.3. By Indication
15.4. Country
15.4.1. Mexico
15.4.2. Brazil
15.4.3. Rest of Latin America
16. Competitive Landscape
16.1. Company market share, 2021
16.2. Key player overview
16.3. Key stakeholders
17. Company Profiles
17.1.Accenture
17.1.1. Company Overview
17.1.2. Financial Overview
17.1.3. Key Product; Analysis
17.1.4. Company Assessment
17.1.4.1. Product Portfolio
17.1.4.2. Key Clients
17.1.4.3. Market Share
17.1.4.4. Recent News & Development (Last 3 Yrs.)
17.1.4.5. Executive Team
17.2. Oracle Corporation
17.3. J&J Innovative Medicine
17.4. IQVIA Holdings Inc.
17.5. Labcorp Drug Development
17.6. ICON Plc
17.7. Dassault Systemes SE
17.8. Parexel International Corporation
17.9. Clario
17.10. Medpace Holdings Inc.
17.11.Measure
17.12. Signant Health
17.13. Medable Inc.
17.14. Clinical Ink
17.15. Croprime
17.16. Other Prominent Players
18. Appendix
19. Consultant Recommendation
Select License Type
Our Clients
We have been working with some Fortune 500+ clients
.png){kind=icon}
